Maryland Guidance Lets Dispensaries Keep Selling Non-Compliant Hemp Products

Maryland draws a line between state and federal hemp rules

Maryland regulators issued guidance allowing dispensaries to keep selling hemp-derived products that don't meet the new federal hemp definition, according to The Marijuana Herald.

That guidance reached the market on November 14, 2026. The signal available to CannIntel doesn't include the guidance text, so the issuing office, effective date, and any sunset provision aren't confirmed here. We'll update as the document is reviewed.

What the federal definition changes

The new federal definition narrows what qualifies as hemp, which is why products that previously sat in a gray zone are now at issue.

On a strict reading, a product outside the federal hemp definition stops being hemp for federal purposes. It doesn't become lawful marijuana by default. Instead it falls back into the Controlled Substances Act's marijuana category, and that's the core exposure.

Why a state carve-out doesn't resolve the federal question

State guidance governs state licensure and nothing more; it doesn't alter federal scheduling.

A Maryland licensee selling these products stays inside the state regulatory frame. Federal status is a separate matter. The guidance can't change it.

Maryland's guidance protects licensees from state-level enforcement, but it can't convert a federally non-compliant product into a federally compliant one.

The 280E problem operators should price in

On a strict reading of IRC §280E, any product reclassified as marijuana for federal purposes pulls the seller toward the statute's deduction bar.

Section 280E disallows ordinary business deductions for trafficking in Schedule I or II substances, and dispensaries already operate under it for their THC sales. Hemp-derived inventory that loses federal hemp status could widen the pool of revenue treated the same way.

• Cost of goods sold: still the one recognized offset, so inventory records matter more.
• Segregation: separate SKU-level accounting for hemp-derived lines becomes a defensible practice.
• Audit posture: classification choices should be documented contemporaneously.

Banking and processor exposure

Financial institutions look to federal status, not state guidance, when they assess risk on a licensee's revenue.

A bank or payment processor that views these products as federally non-compliant hemp may treat the revenue as marijuana-related. That can mean added reporting or account friction. Expect questions.

What operators should do now

The prudent course is to treat the guidance as a state-law safe harbor only and build federal contingency around it.

1. Inventory every hemp-derived SKU and test it against the federal definition.
2. Segregate those lines in the books and in point-of-sale reporting.
3. Get written tax advice on §280E treatment before the next filing deadline.
4. Ask the state for the guidance's legal basis and expiration terms.

What to watch

The next signals are the guidance text itself and any federal response to states that diverge from the new definition.

Operators selling affected products should expect their CPAs, banks, and insurers to ask about federal status before the state does. For background, see the CannIntel topic hub on the federal hemp loophole. Maryland's Cannabis Administration oversees licensees, and the DEA remains the federal wildcard.